Adherium Appoints New CFO
19 sept. 2017 08h00 HE
|
Adherium
SAN MATEO, Calif., Sept. 19, 2017 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, today announced the appointment of Timothy...
Adherium Receives U.S. 510(K) Clearance for Next Generation Smartinhaler for AstraZeneca’s Symbicort Aerosol Inhaler
01 sept. 2017 09h00 HE
|
Adherium
MELBOURNE, Australia, Sept. 01, 2017 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, today announced U.S. Food and Drug...
Adherium Appoints New CEO to Drive Global Growth
09 juin 2017 10h13 HE
|
Adherium
MELBOURNE, Australia, June 09, 2017 (GLOBE NEWSWIRE) -- Adherium Limited (ASX:ADR), a global leader in digital health technologies that address sub-optimal medication use in chronic disease, today...
UK’s NICE acknowledges Adherium’s Smartinhaler™ more effective than current practice in improving adherence to asthma medication
12 janv. 2017 07h00 HE
|
Adherium
MELBOURNE, Australia, Jan. 12, 2017 (GLOBE NEWSWIRE) -- Adherium Limited (‘Adherium’ or the ‘Company’) (ASX:ADR), a global leader in digital health technologies that address sub-optimal medication...
Adherium appoints digital health pioneer to lead European business development
10 janv. 2017 09h16 HE
|
Adherium
Digital health veteran to join expanding global team MELBOURNE, Australia, Jan. 10, 2017 (GLOBE NEWSWIRE) -- Adherium Limited (ASX:ADR), a global leader in digital health technologies that address...
Adherium’s Smartinhaler™ Technology Chosen for Major Asthma Initiative
09 déc. 2016 07h00 HE
|
Adherium
MELBOURNE, Australia, Dec. 09, 2016 (GLOBE NEWSWIRE) -- Adherium Limited (ASX:ADR), a global leader in digital health technologies that address sub-optimal medication use in chronic disease, today...
Independent clinical study shows Adherium’s Smartinhaler™ dramatically improves clinical outcomes and medication adherence in children with asthma
17 nov. 2016 07h00 HE
|
Adherium
Five-fold reduction in asthma-related hospitalisations observed in patients using Adherium’s Smartinhaler™Smartinhaler™ use resulted in sustained increase in medication adherence and significant...
Adherium Announces Key Technology Patent Granted in US
20 oct. 2016 07h00 HE
|
Adherium
MELBOURNE, Australia, Oct. 20, 2016 (GLOBE NEWSWIRE) -- Adherium Limited (ASX:ADR), a global leader in digital health technologies that address sub-optimal medication use in chronic disease, today...
Adherium to Supply AstraZeneca Australia With Smartinhaler™ Platform for a Joint Commercial Pilot Program
16 août 2016 07h00 HE
|
Adherium
MELBOURNE, Australia, Aug. 16, 2016 (GLOBE NEWSWIRE) -- Adherium Limited (ASX:ADR), a global leader in digital health technologies that address sub-optimal medication use in chronic disease, today...
Adherium Executes $8m Share Placement to Fidelity International
20 juil. 2016 07h00 HE
|
Adherium
MELBOURNE, Australia, July 20, 2016 (GLOBE NEWSWIRE) -- Adherium Limited (ASX:ADR) announces that it has entered into a binding agreement for an $8 million share placement to Fidelity International,...